The purpose of the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT) was to determine whether acetazolamide is beneficial in improving vision when added to a low sodium, weight reduction diet in idiopathic intracranial hypertension (IIH) patients with mild visual loss. During the first six months of the intervention phase, six subjects on placebo and one subject on acetazolamide met criteria for treatment failure. Male patients, those with high grade papilledema and those with decreased visual acuity at baseline were more likely to experience treatment failure.
Relation is Part of
NANOS Annual Meeting 2015 Sizzling Hot Topic: The IIHTT: What Have We Learned?
Spencer S. Eccles Health Sciences Library, University of Utah
2015 North American Neuro-Ophthalmology Society Annual Meeting